PHA Classroom banner


>> Back to Recordings
 
Session Recording from 2011
PHA on the Road, Minneapolis

Initial PAH Treatment: What Are the Choices and Which One Is Best for Me?

June 18, 2011

Current treatment options for PAH have dramatically expanded over the past several years. This segment will discuss all the approved therapies, and some of the factors that influence the choice of therapy for an individual patient.

View the recording (recording will open in a new window)

Presenter Information

James R. Flink, MD, St. Paul Lung Clinic, St. Paul, Minn.  
 

>>If you liked this recording, you may enjoy Long-Term PAH Management: Ways to Be Followed and When to Modify Treatment Regimens

Robert Frantz, MD

DIAMOND
SUPPORTER

PLATINUM
SUPPORTER

GOLD
SUPPORTER

GOLD
SUPPORTER

Actelion Pharmaceuticals US, Inc. Gilead Sciences, Inc. Bayer HealthCare United Therapeutics Corporation
 
This is a program of the PHA Medical Education Fund, made possible through unrestricted educational grants from our supporters.

 

FacebookTwitterLinkedInYouTube

For optimal viewing of PHAssociation.org, please use a standards-compliant browser such as Google Chrome or Firefox.

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
Webmaster@PHAssociation.org
    Privacy Policy    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2015 Pulmonary Hypertension Association. All Rights Reserved.

NORD

The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.